Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.
Qing GuoGe-Fei GuanWen ChengCun-Yi ZouChen ZhuPeng ChengAn-Hua WuPublished in: CNS neuroscience & therapeutics (2018)
We identified CAVIN1 as a prognostic biomarker and potential target for developing novel therapeutic strategies against GBM.